TABLE 2.
Values of pharmacokinetic parameters for GS 4071 following i.v. administration of GS 4071 or oral administration of GS 4104 to animalsa
Species | Compound | Dose (mg-eq/kg), route of administration | AUC0–24 (mg · h/liter) | Cmax (μg/ml) | Tmax (h) | CL (liters/h/kg) | t1/2 (h) | VSS (liters/kg) | F (%) |
---|---|---|---|---|---|---|---|---|---|
Mouse (n = 3) | GS 4071 | 10, i.v. | 13 | 0.77 | NDb | 3.9 | |||
GS 4104 | 10, oral | 3.9 | 1.2 | 1.0 | ND | 30 | |||
Rat (n = 4) | GS 4071 | 10, i.v. | 8.4 | 1.5 | 1.6 | 1.3 | |||
GS 4104 | 10, oral | 3.0 | 0.47 | 1.6 | 7.0 | 35 | |||
Ferret (n = 3) | GS 4071 | 1, i.v. | 2.2 | 0.33 | 0.6 | 0.28 | |||
GS 4104 | 5, oral | 1.2 | 0.20 | 2.0 | 5.7 | 11 | |||
Dog (n = 5) | GS 4071 | 5, i.v. | 18 | 0.32 | 1.8 | 0.56 | |||
GS 4104 | 5, oral | 11 | 1.2 | 3.8 | 3.7 | 73 |
Values are means and are based on the levels of GS 4071 in plasma.
ND, not determined.